News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
489,711 Results
Type
Article (8078)
Company Profile (147)
Press Release (481486)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166771)
Career Advice (304)
Deals (25744)
Drug Delivery (7)
Drug Development (52896)
Employer Resources (14)
FDA (9764)
Job Trends (8577)
News (238243)
Policy (17907)
Tag
2025 Best Places to Work (5)
2026 Best Places to Work (12)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (1)
Academia (503)
Accelerated approval (31)
ADA (18)
Adcomms (1)
Allergies (103)
Alliances (33163)
ALS (122)
Alzheimer's disease (1017)
Antibody-drug conjugate (ADC) (338)
Approvals (10498)
Artificial intelligence (382)
ASCO (162)
Autoimmune disease (259)
Automation (34)
Bankruptcy (264)
Belgium (4)
Best Places to Work (6962)
BIO (36)
Biologics (61)
BIOSECURE Act (1)
Biosimilars (126)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (30)
Bladder cancer (150)
Brain cancer (37)
Breast cancer (553)
Cancer (4136)
Cardiovascular disease (247)
Career advice (245)
Career pathing (1)
CAR-T (195)
CDC (2)
CDMO (36)
Celiac Disease (3)
Cell therapy (534)
Cervical cancer (37)
Clinical research (48643)
Collaboration (1382)
Commercialization (34)
Compensation (1666)
Complete response letters (36)
COVID-19 (780)
CRISPR (75)
C-suite (872)
Cystic fibrosis (89)
Data (6713)
Denatured (4)
Depression (109)
Dermatology (106)
Diabetes (389)
Diagnostics (4285)
Digital health (43)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (176)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (176)
Earnings (74513)
Editorial (1)
Employer branding (2)
Employer resources (14)
ESMO (240)
Events (89245)
Executive appointments (744)
Eye disease (7)
FDA (12745)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (21)
Frontotemporal dementia (25)
Funding (1010)
Gene editing (140)
Generative AI (15)
Gene therapy (359)
GLP-1 (319)
Government (957)
Grass and pollen (2)
Guidances (288)
Healthcare (9449)
Hematology (115)
HIV (60)
Huntington's disease (30)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (82)
Immunology and inflammation (114)
Immuno-oncology (75)
Indications (189)
Infectious disease (991)
Inflammatory bowel disease (145)
Inflation Reduction Act (4)
Influenza (90)
Intellectual property (275)
Interviews (41)
IPO (12402)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (19)
Kidney disease (91)
Layoffs (61)
Legal (5198)
Licensing (65)
Liver cancer (47)
Longevity (28)
Lung cancer (591)
Lung diease (11)
Lymphoma (282)
Machine learning (30)
Management (3)
Manufacturing (630)
Marketing (25)
MASH (131)
Medical affairs (2)
Medical device (8728)
Medtech (8930)
Mergers & acquisitions (14492)
Metabolic disorders (792)
mRNA (82)
Multiple sclerosis (118)
Multispecific (3)
NASH (4)
Netherlands (4)
Neurodegenerative disease (250)
Neuropsychiatric disorders (41)
Neuroscience (1991)
Neurotech (2)
NextGen: Class of 2026 (3151)
Non-profit (845)
Obesity (246)
Opinion (11)
Ovarian cancer (184)
Pain (195)
Pancreatic cancer (237)
Parkinson's disease (220)
Partnered (12)
Patents (532)
Patient advocacy (3)
Patient recruitment (550)
Patient selection (55)
Peanut (34)
People (41587)
Peptides (24)
Pharmaceutical (30)
Pharmacy benefit managers (11)
Phase 1 (15706)
Phase 2 (21753)
Phase 3 (14683)
Pipeline (9037)
Policy (21)
Postmarket research (1570)
Preclinical (6620)
Press Release (34)
Prostate cancer (211)
Psychedelics (12)
Radiopharmaceuticals (205)
Rare diseases (640)
Real estate (3025)
Recruiting (6)
Regenerative medicine (18)
Regulatory (15261)
Reports (27)
Research institute (597)
Resumes & cover letters (45)
Rett syndrome (47)
RNA editing (9)
RSV (52)
Schizophrenia (111)
Series A (179)
Series B (128)
Service/supplier (5)
Sickle cell disease (70)
Spinal muscular atrophy (93)
Sponsored (5)
Startups (2022)
Stem cells (3)
Stomach cancer (3)
Substance use disorders (17)
Supply chain (56)
Switzerland (2)
Tariffs (2)
Vaccines (361)
Venture capital (18)
Weight loss (79)
Wet AMD (3)
Women's health (102)
Date
Last 7 days (624)
Last 30 days (2235)
Last 365 days (19114)
2026 (17266)
2025 (19255)
2024 (22992)
2023 (26539)
2022 (34599)
2021 (37177)
2020 (33483)
2019 (23265)
2018 (17473)
2017 (18775)
2016 (17918)
2015 (24264)
2014 (21679)
2013 (18136)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (233)
Alabama (81)
Alaska (2)
Arizona (331)
Arkansas (12)
Asia (18107)
Australia (2129)
California (13387)
Canada (3451)
China (594)
Colorado (549)
Connecticut (471)
Delaware (236)
Europe (24865)
Florida (1992)
Georgia (420)
Hawaii (3)
Idaho (46)
Illinois (802)
India (66)
Indiana (339)
Iowa (19)
Japan (466)
Kansas (105)
Kentucky (34)
Louisiana (30)
Maine (27)
Maryland (1317)
Massachusetts (8759)
Michigan (325)
Minnesota (623)
Mississippi (5)
Missouri (86)
Montana (20)
Nebraska (11)
Nevada (140)
New Hampshire (61)
New Jersey (2944)
New Mexico (12)
New York (3121)
North Carolina (1416)
North Dakota (4)
Northern California (6804)
Ohio (311)
Oklahoma (15)
Oregon (17)
Pennsylvania (2493)
Puerto Rico (24)
Rhode Island (32)
South America (407)
South Carolina (81)
South Dakota (1)
Southern California (5594)
Tennessee (131)
Texas (2209)
United States (43279)
Utah (405)
Vermont (1)
Virginia (169)
Washington D.C. (39)
Washington State (1019)
West Virginia (1)
Wisconsin (84)
Wyoming (1)
489,711 Results for "immunomedics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
Policy
Former CFO of Gilead’s Immunomedics Indicted for Fraud, Insider Trading (Updated)
Usama Malik, the former chief financial officer of Immunomedics, has been indicted for insider trading, five months after the U.S. Securities and Exchange Commission leveled charges.
May 11, 2022
·
3 min read
·
Alex Keown
Business
Gilead Braces For 114 Job Cuts at Former Immunomedics Facility
Gilead Sciences is letting go of 114 employees following an underwhelming response to the results reaped so far from its $21 billion acquisition of Immunomedics in 2020.
March 10, 2022
·
2 min read
·
Vanessa Doctor, RN
Deals
Gilead Sciences Completes Acquisition of Immunomedics, Inc.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire Immunomedics, Inc. (Nasdaq: IMMU) for approximately $21 billion in the aggregate.
October 23, 2020
·
6 min read
Press Releases
Mint Pharmaceuticals Inc. and Bayer Inc. Expand Distribution Partnership in Canada
October 6, 2026
·
3 min read
Press Releases
Exicure, Inc. Announces Agreement to Sell GPC-100 Program Assets to GPCRT Inc. for KRW 6.5 Billion
November 10, 2026
·
4 min read
Pharm Country
Immunomedics to Participate in Upcoming Healthcare Conferences
Immunomedics, Inc.(NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced that the Company will participate in fireside chats at the following healthcare conferences:
February 25, 2020
·
3 min read
Press Releases
PharmaCyte Biotech, Inc. Announces Reverse Stock Split
November 11, 2026
·
3 min read
Business
Immunomedics Reports First Quarter 2020 Results and Provides Corporate Update
Immunomedics, Inc. reported financial results for the first quarter of 2020.
May 6, 2020
·
13 min read
Deals
IMMUNOMEDICS LOSSES ALERT: BERNSTEIN LIEBHARD LLP ANNOUNCES INVESTIGATION OF IMMUNOMEDICS, INC. - IMMU
Bernstein Liebhard LLP is investigating potential securities fraud claims on behalf of shareholders of Immunomedics, Inc. resulting from allegations that Immunomedics and/or its executives may have issued materially misleading business information to the investing public.
December 21, 2018
·
2 min read
1 of 48,972
Next
